The RNA Renaissance continues

How Disney’s Scripps lab has expanded the RNA target universe

Two papers from Matthew Disney’s lab at The Scripps Research Institute herald a pair of RNA-related discoveries: a method for engineering small molecules that target and cleave oncogenic microRNAs, and a platform that identified RNA-targeting capabilities in three approved cancer drugs.

The findings contribute to growing evidence that RNAs are therapeutically relevant targets for small molecules and offer new ways to target miRNAs (see “Structured Outlook”).

“We are

Read the full 665 word article

User Sign In